Discontinued Operations, Sale of Clinical Labs Business (Details) - Schedule of Condensed Operating Results of the Discontinued Operations - Parent [Member] - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Jul. 31, 2024 |
Jul. 31, 2023 |
|
| Schedule of Condensed Operating Results of the Discontinued Operations [Line Items] | ||
| Net revenues | $ 30,087 | |
| Cost of revenues | 36,947 | |
| Selling, general and administrative | 3,723 | 23,270 |
| Research and development | 720 | |
| Legal and related expenses | 250 | |
| Other expense | 12,928 | 6,221 |
| Loss from discontinued operations | (16,651) | (37,321) |
| Gain on sale of business – before taxes | 83,491 | |
| Income tax refund (expense) on gain | 390 | (860) |
| (Loss) income from discontinued operations | $ (16,261) | $ 45,310 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Research and development. No definition available.
|
| X | ||||||||||
- Definition Selling, general and administrative. No definition available.
|
| X | ||||||||||
- Definition Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|